当前位置:首页 - 行情中心 - 丰原药业(000153) - 财务分析 - 现金流量表

丰原药业

(000153)

  

流通市值:31.18亿  总市值:31.47亿
流通股本:4.61亿   总股本:4.65亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,477,831,768.621,601,266,628.71781,358,331.183,463,113,510.18
  收到的税费返还3,542,584.152,414,216.281,531,336.315,029,097.81
  收到其他与经营活动有关的现金66,044,948.638,986,235.9122,101,897.04337,844,690.64
  经营活动现金流入小计2,547,419,301.371,642,667,080.9804,991,564.533,805,987,298.63
  购买商品、接受劳务支付的现金1,713,106,954.991,101,849,947.52508,020,372.032,358,196,622.09
  支付给职工以及为职工支付的现金309,789,737.35210,708,151.68123,655,072.29419,822,145.05
  支付的各项税费149,514,812.42104,726,728.1756,419,902.11211,772,462.27
  支付其他与经营活动有关的现金286,194,244.81197,239,363.61104,563,902.87689,960,920.01
  经营活动现金流出小计2,458,605,749.571,614,524,190.98792,659,249.33,679,752,149.42
  经营活动产生的现金流量净额88,813,551.828,142,889.9212,332,315.23126,235,149.21
二、投资活动产生的现金流量:
  收回投资收到的现金1,400,0001,400,0001,400,00025,816,556.6
  取得投资收益收到的现金8,477,122.5--9,271,305.32
  处置固定资产、无形资产和其他长期资产收回的现金净额131,262.7529,772.758,898.75473,786
  投资活动现金流入小计10,008,385.251,429,772.751,408,898.7535,561,647.92
  购建固定资产、无形资产和其他长期资产支付的现金165,372,565.71133,351,252.9391,534,251.72144,015,906.34
  投资支付的现金---143,000,472.47
  投资活动现金流出小计165,372,565.71133,351,252.9391,534,251.72287,016,378.81
  投资活动产生的现金流量净额-155,364,180.46-131,921,480.18-90,125,352.97-251,454,730.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金---4,660,000
  其中:子公司吸收少数股东投资收到的现金---4,660,000
  取得借款收到的现金967,314,958.53656,357,601.84328,585,943.071,155,685,392.17
  筹资活动现金流入小计967,314,958.53656,357,601.84328,585,943.071,160,345,392.17
  偿还债务支付的现金791,242,029.58513,894,188231,000,0001,002,755,589.58
  分配股利、利润或偿付利息支付的现金70,053,675.560,853,537.087,184,098.3872,171,160
  支付其他与筹资活动有关的现金20,227,814.613,423,842.426,643,022.1734,792,295.67
  筹资活动现金流出小计881,523,519.68588,171,567.5244,827,120.551,109,719,045.25
  筹资活动产生的现金流量净额85,791,438.8568,186,034.3483,758,822.5250,626,346.92
四、汇率变动对现金及现金等价物的影响-8,113.59-2,953.17742.75166,346.15
五、现金及现金等价物净增加额19,232,696.6-35,595,509.095,966,527.53-74,426,888.61
  加:期初现金及现金等价物余额216,312,023.86216,312,023.86216,312,023.86290,738,912.47
  期末现金及现金等价物余额235,544,720.46180,716,514.77222,278,551.39216,312,023.86
补充资料:
  净利润-75,002,400.41-157,650,906.74
  资产减值准备-6,096,773.37-14,950,908.74
  固定资产和投资性房地产折旧-52,104,741.5-87,650,171.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-52,104,741.5-87,650,171.72
  无形资产摊销-7,823,891.96-13,138,500.23
  长期待摊费用摊销-7,407,372.43-16,095,598.24
  处置固定资产、无形资产和其他长期资产的损失---1,613,956.1
  固定资产报废损失-59,287.73-8,906.97
  公允价值变动损失-710,807.5-5,283,485.49
  财务费用-15,874,108.64-30,246,938.07
  投资损失-600--9,220,093.88
  递延所得税--2,069,409.76--1,258,029.94
  其中:递延所得税资产减少--2,274,207.45-1,249,375.66
    递延所得税负债增加-204,797.69--2,507,405.6
  存货的减少-34,721,375.65--18,380,039.34
  经营性应收项目的减少--154,789,138.12--165,390,536.11
  经营性应付项目的增加--26,763,941.47--33,202,668.52
  其他--1,753,112.03--
  现金的期末余额-180,716,514.77-216,312,023.86
  减:现金的期初余额-216,312,023.86-290,738,912.47
  现金及现金等价物的净增加额--35,595,509.09--74,426,888.61
公告日期2025-10-242025-08-222025-04-252025-04-11
审计意见(境内)标准无保留意见
TOP↑